Baby Claw sits further down the market cap rankings at #13153, which weighs on the fundamentals score relative to more dominant names in the token category. Baby Claw has no protocol or chain reporting fees or value secured, so on-chain health rests on turnover: 24h volume at roughly 0.0% of market cap. That is thin, which can mean wider spreads and choppier price action.
Momentum has been constructive lately, with price up +56177.8% over the trailing 7 days. The risk pillar is holding up reasonably well, with 24h price action of -0.7% that doesn't suggest acute stress.
The composite grade of D puts Baby Claw at the 19th percentile of the rated universe on a weighted blend of fundamentals (35%), on-chain health (25%), momentum (20%), and inverted risk (20%). See the Methodology page for how each pillar is defined.
Every Antelux grade is mechanical: no analyst overrides. Each pillar below shows the exact measured input, and its score is a percentile rank against the other rated coins on that measure, so 90 means it beats 90% of the universe rather than scoring 90 out of 100. Full methodology, weightings, and grade bands are on the Methodology page.
Blends market standing with tokenomics. Rank #13153 caps the sub-score, and with 100% of max supply already circulating, little future dilution overhangs holders.
The composite score recorded for Baby Claw at the end of each day. Because the score is a percentile rank within the rated universe, a flat line means Baby Claw held its place relative to everything else, not that nothing happened to it.